A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help ...

The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.

In this brief article, I will summarize and discuss the diagnosis and treatment of this disease. For diagnosis of dengue, most tropical doctors make use of presumptive diagnosis; however ...

Severe dengue infection can lead to death, therefore, clinicians should should aim for prompt diagnosis and treatment. Presumptive diagnosis of dengue is still widely used in the clinical setting.

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help ...

Australian antiviral drug development company Island Pharmaceuticals has completed subject dosing for the phase 2b ...

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.

The illness typically lasts two to seven days, but severe cases can be deadly. An affected person will have flu-like symptoms ...

In severe cases, dengue can be fatal. Dengue is treated with pain medicine as there is no specific treatment currently. Therefore people should be aware of the risks of dengue fever.  According to the ...

NIH-funded clinical trial will evaluate new dengue therapeutic: Bethesda, Maryland Thursday, February 13, 2025, 11:00 Hrs [IST] A clinical trial supported by the National Institut ...